The Treatment of Obstructive Hypertrophic Cardiomyopathy is best in Higher-Volume Hospitals
May 12, 2016
NEW YORK (Reuters Health) - Higher-volume hospitals do better in treatment of obstructive hypertrophic cardiomyopathy (HCM), but more efforts are needed to direct patients to these centers, according to New York-based researchers. In an April 27 online paper in JAMA Cardiology, they note that rec
Prior clopidogrel tied to more events in medically treated ACS patients
April 27, 2016
NEW YORK (Reuters Health) - Among medically treated patients with acute coronary syndrome (ACS), prior clopidogrel therapy appears to be associated with more cardiovascular events, researchers have found. As Dr.
Edoxban has Advantages over Warfarin for Patients with Venous Thromboembolism
April 18, 2016
NEW YORK (Reuters Health) - Edoxaban (Savaysa, Daiichi-Sankyo) shows advantages over warfarin in long-term treatment of patients with venous thromboembolism (VTE), according to a post-hoc analysis of multinational trial data. As Dr.
Researchers Say Procalcitonin is Linked to Shorter Treatment and Reduced Mortality in Critically Ill
March 22, 2016
NEW YORK (Reuters Health) - Use of the marker procalcitonin to guide antibacterial therapy in the critically ill is associated with shorter treatment and reduced mortality, according to Dutch researchers. As Dr.
CRT in Patients with Heart Failure Without LBBB May Harm
March 4, 2016
NEW YORK (Reuters Health) - Cardiac resynchronization therapy (CRT) in patients with heart failure (HF) without left bundle branch block (LBBB) may not help and might even harm, according to an international group of investigators. As Dr.
Survival is Heightened with the Use of Bisphophonate
February 17, 2016
NEW YORK (Reuters Health) - Bisphosphonate use is associated with better survival in patients admitted to the intensive care unit (ICU), according to Australian researchers. As Dr.
Compared to Open Repair, EVAR Reduces Mortality up to 3 Years
September 22, 2015
NEW YORK - Endovascular repair (EVAR) of abdominal aortic aneurysms (AAAs) is associated with an initial survival advantage over open repair, according to a study of "real-world" data from California. However, the difference disappears in the long term, researchers report in JAMA Surgery, online
Increased VTE Prophylaxis Shows Little Benefit following Colorectal Surgery
June 18, 2015
NEW YORK—Although venous thromboembolism (VTE) rates are low in hospitalized patients following colorectal surgery, the increasing use of prophylaxis seems to have little impact, according to Washington state-based researchers. Dr. Scott R.